Quercetin for Interstitial Cystitis: Does It Work?

If you spend time in interstitial cystitis forums, quercetin comes up a lot. It’s a plant flavonoid found in onions, apples, and berries, and it’s one of the few natural compounds that has been tested specifically in IC patients. Not just in rats. In actual people with diagnosed IC.

That alone makes it worth paying attention to. Most supplements marketed for bladder pain have zero clinical data behind them. Quercetin at least has a published trial, a plausible mechanism, and enough biochemistry to explain why it might work. Whether the evidence is strong enough to recommend it is a different question, and that’s what I’ll break down here.

Why Quercetin Interests IC Researchers

Quercetin belongs to a class of compounds called bioflavonoids. It’s one of the most studied flavonoids in nutrition research, with over 7,000 published papers. But what makes it specifically relevant to interstitial cystitis comes down to one thing: mast cells.

People with IC often have elevated mast cell counts in their bladder tissue 1. Mast cells release histamine, and histamine levels in IC bladders can be roughly twice that of healthy bladders. This histamine flood triggers the burning, urgency, and frequent urination that define the condition.

Quercetin is a natural mast cell stabilizer. It blocks mast cells from releasing histamine and other inflammatory mediators like TNF-alpha, IL-6, and IL-1 beta 2. This is the same basic approach that prescription mast cell stabilizers use, just through a different pathway.

Beyond mast cell stabilization, quercetin works through at least two other mechanisms relevant to IC:

• Anti-inflammatory action. Quercetin inhibits both COX-1 and COX-2 enzymes and blocks NF-kB, a key inflammatory signaling pathway. In rat models of IC, quercetin treatment significantly reduced levels of MPO, IL-1 beta, IL-6, and TNF-alpha in serum 2.
• GAG layer support. A 2024 bioinformatics study found that quercetin upregulates a gene called Lpl (lipoprotein lipase), which in turn promotes glycosaminoglycan production in the bladder. This is significant because the GAG layer is the protective coating that’s often damaged in IC patients 2.

So you have triple coverage: block the histamine response, reduce general inflammation, and potentially help rebuild the bladder’s protective layer. That’s a better theoretical profile than most IC supplements can claim.

The CystaQ Clinical Trial

The most important piece of evidence for quercetin in IC is the Katske-Shoskes trial, published in 2001 1.

Twenty-two patients (5 men, 17 women, average age 53) with classically documented IC received CystaQ, a supplement providing 500 mg of quercetin per capsule, taken twice daily for 4 weeks. Twenty patients completed the study.

The results were striking:

• IC Problem Index: dropped from 11.3 to 5.1 (p = 0.000001)
• IC Symptom Index: dropped from 11.9 to 4.5 (p = 0.000001)
• Global Pain Assessment: dropped from 8.2 to 3.5 on a 0-10 scale (p = 0.000001)

That’s a reduction of more than 50% across all three measures, and 19 out of 20 completers showed improvement. No adverse side effects were reported.

Now, the caveats. This was an open-label study with no placebo group. Twenty patients is small. The p-values are impressive, but without blinding, you can’t rule out the placebo effect. Dr. Shoskes, the lead researcher, acknowledged this and called for larger randomized controlled trials. Over 20 years later, those trials still haven’t happened for quercetin alone in IC patients.

That said, the magnitude of improvement is hard to explain entirely by placebo. A drop in pain scores from 8.2 to 3.5 is meaningful by any standard.

What About CystoProtek?

A related product called CystoProtek combines quercetin with chondroitin sulfate, hyaluronic acid, and glucosamine sulfate. A pilot study tested this combination in IC patients and found reduced symptom severity over 12 months of monitoring 3.

The logic behind combining quercetin with GAG-layer precursors makes sense. You get the anti-inflammatory and mast cell effects from quercetin, plus direct GAG layer rebuilding from chondroitin and hyaluronic acid. Several IC specialists recommend this type of combination approach rather than quercetin alone.

If you’re already taking supplements for IC, check whether your current stack includes quercetin. It’s sometimes listed under “bioflavonoid complex” rather than by name.

The Bioavailability Problem

Here’s something most articles about quercetin for IC don’t mention: quercetin has poor oral bioavailability. Your gut absorbs only a fraction of what you swallow, and the liver rapidly metabolizes what does get absorbed.

This matters because the impressive trial results used a specific formulation (CystaQ) designed to improve absorption. Taking cheap quercetin powder in a basic capsule might not deliver the same results.

A few strategies can help with absorption:

Take it with bromelain. Bromelain, a pineapple-derived enzyme, may increase quercetin absorption by 30-50% according to some estimates. Many quercetin supplements now include bromelain for this reason. The CystaQ formulation used in the IC trial included bromelain and papain alongside quercetin.

Take it with fat. Quercetin is fat-soluble. Taking it with a meal that includes some dietary fat improves uptake compared to taking it on an empty stomach.

Consider phytosome forms. Newer quercetin supplements use phytosome technology (quercetin bound to phospholipids), which protects the compound from degradation in the gut. While no IC-specific trials have used phytosome quercetin, the bioavailability improvements are well-documented for other quercetin applications.

How Quercetin Compares to Other IC Supplements

Quercetin isn’t the only natural option for interstitial cystitis. Here’s how it stacks up against other commonly used supplements:

Aloe vera has an 87.5% response rate in a small pilot trial and a much larger patient survey (600+ patients, 92% reporting some relief). It works primarily through GAG layer repair rather than mast cell stabilization. Some patients take both quercetin and aloe vera together.

Probiotics target the gut-bladder axis and may reduce systemic inflammation that contributes to IC flares. They work through a completely different pathway and can be combined with quercetin.

Marshmallow root provides temporary physical coating of the bladder lining through its mucilage content. It offers more immediate soothing but doesn’t address the mast cell component the way quercetin does.

D-mannose is primarily useful for UTI prevention rather than IC symptom management. If your IC symptoms overlap with recurrent UTIs, it might be a useful addition.

Of these, quercetin has the most direct mechanism for addressing mast cell-driven IC. If your IC specialist suspects mast cell involvement in your case, quercetin is worth discussing.

Dosing and Practical Tips

Based on the available evidence and common clinical practice:

Standard dose: 500 mg twice daily (1,000 mg total per day), matching the CystaQ trial protocol. Some people start lower at 250 mg twice daily and work up.

Duration: Give it at least 4 weeks before judging whether it’s working. The clinical trial showed benefits at the 4-week mark.

Timing: Take with meals that contain some fat. Split the dose morning and evening rather than taking it all at once.

Form: Look for quercetin combined with bromelain or in phytosome form for better absorption. Avoid products that list quercetin as part of a “proprietary blend” without specifying the actual quercetin dose.

Food sources: Onions (especially red onions, about 39 mg per 100g), apples (about 5 mg per 100g), capers (highest food source at 234 mg per 100g), berries, and dark leafy greens all contain quercetin. But dietary intake typically ranges from 10 to 50 mg daily, far below the 1,000 mg used in the trial.

Safety and Interactions

Quercetin has a good safety profile at standard supplement doses. The IC trial reported zero adverse effects, and quercetin supplements have been used in doses up to 1,000 mg daily for up to 12 weeks in various studies without significant safety concerns 4.

However, there are some interactions to be aware of:

• Antibiotics. Quercetin can increase the effectiveness of certain antibiotics (fluoroquinolones in particular). If you’re on antibiotics for a UTI, mention your quercetin use to your doctor.
• Blood thinners. Quercetin may have mild antiplatelet effects. If you take warfarin or similar medications, your doctor should monitor your levels.
• Cyclosporine. Quercetin can increase blood levels of cyclosporine, which is itself sometimes used for severe IC.
• Liver-metabolized drugs. Quercetin affects certain cytochrome P450 enzymes, potentially altering how the liver processes other medications.

Pregnant and breastfeeding women should avoid quercetin supplements due to insufficient safety data.

When to See a Doctor

Quercetin is a supplement, not a treatment plan. If you’re experiencing bladder pain, urgency, or painful urination that’s affecting your daily life, see a urologist or urogynecologist before self-treating with supplements.

Seek medical attention right away if you notice blood in your urine, sudden worsening of symptoms, fever with bladder symptoms, or an inability to urinate. These may point to conditions that require immediate treatment.

If you’ve already been diagnosed with IC and want to try quercetin, bring the CystaQ trial data to your appointment. Most IC specialists are familiar with it, and having that conversation with your doctor ensures quercetin won’t interact with your current medications.

Frequently Asked Questions

Does quercetin help interstitial cystitis?

Quercetin showed promising results in a clinical trial involving 22 IC patients. After 4 weeks of taking 500 mg twice daily, 19 out of 20 patients who completed the study reported significant improvement in symptoms, pain scores, and quality of life. However, this was a small open-label trial without a placebo group, so the evidence is preliminary. The mast cell stabilization mechanism is well-established in lab research.

How much quercetin should I take for IC?

The main IC clinical trial used 500 mg of quercetin twice daily (1,000 mg total per day) for 4 weeks. Some practitioners recommend taking it with bromelain to improve absorption. Always start with a lower dose and discuss supplementation with your doctor before beginning, especially if you take other medications.

How long does quercetin take to work for bladder pain?

In the CystaQ clinical trial, patients were assessed after 4 weeks and most showed significant improvement by that point. Some people report noticing changes within 2 to 3 weeks. Quercetin is not a quick fix, and consistent daily use for at least a month is typically recommended before evaluating results.

Is quercetin safe for IC patients?

Quercetin is generally well-tolerated. The IC clinical trial reported no adverse side effects. However, quercetin can interact with antibiotics, blood thinners, and cyclosporine. It may also affect how the liver processes certain medications. Pregnant or breastfeeding women should avoid quercetin supplements.

Can I get enough quercetin from food to help IC?

Quercetin is found in onions, apples, berries, and capers, but dietary intake typically provides only 10 to 50 mg per day. The clinical trial used 1,000 mg daily, which is far more than food alone can provide. Supplementation is needed to reach therapeutic doses, though eating quercetin-rich foods may still support overall bladder health.

Can I take quercetin with other IC supplements?

Yes, quercetin can generally be combined with other IC supplements like aloe vera or probiotics. In fact, some formulations like CystoProtek deliberately combine quercetin with chondroitin sulfate and hyaluronic acid. Discuss your full supplement stack with your doctor to avoid interactions.

Summary

Quercetin for interstitial cystitis has a better evidence base than many IC supplements, though it still falls short of a definitive answer. The CystaQ trial showed over 50% improvement in symptom scores, pain, and quality of life in a small group of IC patients. The mechanism is sound: mast cell stabilization, anti-inflammatory action, and potential GAG layer support. A 2024 bioinformatics study added new detail to the molecular pathways involved.

The main limitations are the small trial size and lack of a placebo-controlled study. But for a natural supplement, the consistency between clinical data, lab research, and patient reports is better than average.

If you’re managing IC and looking for something to discuss with your doctor, quercetin, particularly in a formulation with bromelain for better absorption, is a reasonable option to bring up.

References

1. Katske F, Shoskes DA, Sender R, et al. Treatment of interstitial cystitis with a quercetin supplement. Tech Urol. 2001;7(1):44-46. PubMed
2. Zhang Y, et al. Identification of key pathways and mRNAs in interstitial cystitis/bladder pain syndrome treatment with quercetin through bioinformatics analysis. Aging. 2024;16(8):7348-7366. PMC
3. Theoharides TC, et al. A pilot open label study of CystoProtek in interstitial cystitis. Int J Immunopathol Pharmacol. 2005;18(1):183-188. SAGE
4. Alshehri MM, et al. Exploring the anti-inflammatory effects of phytochemicals in attenuating interstitial cystitis: a literature review. Front Pharmacol. 2025;16:1483548. Frontiers
5. Cao Y, et al. Under-urine-adhered supramolecular hydrogel with linearly sustained quercetin release facilitates hemorrhagic cystitis healing. Adv Sci. 2025. Wiley